$430,000 of ECOLAB INC lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Discussions related to environmental policies and issues including water infrastructure, water reuse, water efficiency, water resource management, and sustainability. Discussions related to energy and water efficiency initiatives. Discussions related to PFAS remediation technology. Discussions related to the implementation of the Pesticide Registration Improvement Act, P.L.117-103. Discussions related to data center water efficiency and energy efficiency. Discussions regarding scope of Sec. 48D investment tax credit; Discussions related to the extension of the Tax Cuts and Jobs Act (P.L.115-97); H.R.1, One Big Beautiful Bill Act. Discussions related to supply chain challenges. Discussions regarding trade policy and tariffs. Discussions regarding sustainable aviation fuel. Discussions regarding permitting reform. Discussions regarding Department of Energy programs for Critical Mineral production, including the use of resins as extraction technology. Discussions regarding biopharmaceutical manufacturing policy. Discussions regarding resin bead manufacturing technology."
You can find more data on corporate lobbying on Quiver Quantitative.
ECL Congressional Stock Trading
Members of Congress have traded $ECL stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ECL stock by members of Congress over the last 6 months:
- REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 1 purchase worth up to $250,000 on 04/07 and 1 sale worth up to $250,000 on 05/08.
- SENATOR JOHN BOOZMAN purchased up to $15,000 on 02/26.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
ECL Insider Trading Activity
ECL insiders have traded $ECL stock on the open market 10 times in the past 6 months. Of those trades, 2 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $ECL stock by insiders over the last 6 months:
- LARRY L BERGER (EVP & CHIEF TECHNICAL OFFICER) sold 10,858 shares for an estimated $2,898,575
- NICHOLAS J. ALFANO (EVP & PRES - GLOBAL INDUSTRIAL) sold 9,930 shares for an estimated $2,519,737
- MACHIEL DUIJSER (EVP & CSCO) sold 5,721 shares for an estimated $1,510,572
- GREGORY B COOK (EVP & PRES - INST GROUP) sold 2,234 shares for an estimated $565,202
- ARTHUR J HIGGINS sold 1,800 shares for an estimated $473,490
- TRACY B MCKIBBEN sold 1,704 shares for an estimated $451,035
- VICTORIA REICH sold 1,300 shares for an estimated $352,300
- DAVID MACLENNAN has made 2 purchases buying 900 shares for an estimated $231,678 and 0 sales.
- JENNIFER J BRADWAY (SVP & CORPORATE CONTROLLER) sold 856 shares for an estimated $228,866
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ECL Hedge Fund Activity
We have seen 703 institutional investors add shares of ECL stock to their portfolio, and 721 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GAMMA INVESTING LLC removed 1,805,741 shares (-99.6%) from their portfolio in Q2 2025, for an estimated $486,538,855
- VONTOBEL HOLDING LTD. added 1,109,585 shares (+119.7%) to their portfolio in Q2 2025, for an estimated $298,966,582
- MORGAN STANLEY added 1,083,941 shares (+18.4%) to their portfolio in Q1 2025, for an estimated $274,800,722
- AUTO-OWNERS INSURANCE CO removed 996,400 shares (-99.6%) from their portfolio in Q2 2025, for an estimated $268,470,016
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 816,729 shares (+47.9%) to their portfolio in Q1 2025, for an estimated $207,057,136
- UBS GROUP AG added 685,184 shares (+77.2%) to their portfolio in Q1 2025, for an estimated $173,707,847
- FIRST TRUST ADVISORS LP added 663,591 shares (+175.3%) to their portfolio in Q1 2025, for an estimated $168,233,590
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ECL Analyst Ratings
Wall Street analysts have issued reports on $ECL in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Baird issued a "Outperform" rating on 07/30/2025
- Citigroup issued a "Buy" rating on 07/30/2025
- Mizuho issued a "Outperform" rating on 07/15/2025
- Stifel issued a "Buy" rating on 04/30/2025
- Seaport Global issued a "Buy" rating on 04/21/2025
- Barclays issued a "Overweight" rating on 04/17/2025
- BMO Capital issued a "Outperform" rating on 03/03/2025
To track analyst ratings and price targets for ECL, check out Quiver Quantitative's $ECL forecast page.
ECL Price Targets
Multiple analysts have issued price targets for $ECL recently. We have seen 11 analysts offer price targets for $ECL in the last 6 months, with a median target of $300.0.
Here are some recent targets:
- Patrick Cunningham from Citigroup set a target price of $315.0 on 07/30/2025
- Andrew Wittmann from Baird set a target price of $300.0 on 07/30/2025
- John Roberts from Mizuho set a target price of $305.0 on 07/15/2025
- Joshua Spector from UBS set a target price of $288.0 on 07/09/2025
- Jason Haas from Wells Fargo set a target price of $260.0 on 05/20/2025
- Shlomo Rosenbaum from Stifel set a target price of $303.0 on 04/30/2025
- Michael Harrison from Seaport Global set a target price of $290.0 on 04/21/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
